Chemical Business Newsbase articles from January 2006

Chemical Business Newsbase archives from January 2006

Royal Dutch Shell plc - Buyback of own shares.
January 31, 2006... (From Chemical Business NewsBase - Press Release) Royal Dutch Shell plc announced that on 31 Jan 2006 it purchased for cancellation 575,000 "A" Shares at a price of EUR 28.23/share. It further announced that on the same date it purchased...

Pacific Ethanol Inc announces debt commitment for Madera ethanol plant construction.
January 31, 2006... (From Chemical Business NewsBase - Press Release) Pacific Ethanol Inc has received commitment letters from Hudson United Bank and Comerica Bank for up to a total of $34 M of debt financing to be used for the construction of its ethanol...

Jacobs Engineering Group receives contract from ConocoPhillips.
January 31, 2006... (From Chemical Business NewsBase - Press Release) Jacobs Engineering Group Inc announced that a subsidiary company received a contract from ConocoPhillips to provide maintenance services at ConocoPhillips' Humber Refinery in Immingham,...

Developing markets drive growth of direct sales for cosmetics and toiletries.
January 31, 2006... (From Chemical Business NewsBase - Press Release) Global sales of cosmetics and toiletries through the direct sales channel rose to $15.4 bn in 2004 ($14.3 bn in 2003), according to a new study by Kline & Co. The study, Global Cosmetics &...

PotashCorp to increase its investment in Sinofert to 20%.
January 31, 2006... (From Chemical Business NewsBase - Press Release) Potash Corp of Saskatchewan Inc (PotashCorp) has provided formal notice of its intention to exercise its option to purchase an additional 10.01% of the shares in Sinochem Hong Kong...

ThermoGenesis Corp announces pricing of offering of common stock.
January 31, 2006... (From Chemical Business NewsBase - Press Release) ThermoGenesis Corp has priced a public offering of 8 M shares of its common stock at $4/share. ThermoGenesis has also granted the underwriters an option to purchase up to an additional...

BD Board declares dividend, payable on 31 Mar 2006.
January 31, 2006... (From Chemical Business NewsBase - Press Release) The Board of Directors of Becton Dickinson and Co (BD) has declared a quarterly dividend of 21.5 cts/common share. The dividend will be payable to holders on 31 Mar 2006 to holders of...

Reports Thiovir active against various influenza A viruses in series of independent preclinical tests.
January 31, 2006... (From Chemical Business NewsBase - Press Release) Adventrx Pharmaceuticals Inc announced that a series of independent preclinical tests confirmed inhibition of influenza A virus by the company's broad spectrum anti-viral drug, Thiovir....

Sunesis commences Phase I clinical trial of SNS-032 for cancer.
January 31, 2006... (From Chemical Business NewsBase - Press Release) Sunesis Pharmaceuticals Inc (Sunesis) announced that patient treatment has commenced in a Phase I clinical trial of SNS-032. SNS-032 is a novel small molecule inhibitor of cyclin-dependent...

Sucampo obtains FDA approval for Amitiza capsules as treatment for chronic idiopathic constipation in adults.
January 31, 2006... (From Chemical Business NewsBase - Press Release) Sucampo Pharmaceuticals Inc announced that the US Food and Drug Administration has approved the new drug application for Amitiza (lubiprostone) capsules, an oral treatment of chronic...

Microbix takes over production of urokinase, and is currently negotiating the exclusive right to manufacture the drug for a new proprietary use.
January 31, 2006... (From Chemical Business NewsBase - Press Release) Microbix Biosystems Inc announced that it has taken over the production of its urokinase product from Genpharm Inc and will directly operate the manufacturing facilities. The two...

Baxter Healthcare Corp, One Baxter Parkway, Deerfield, IL 60015, USA, Tel: +1 847 948 2000, Website: http://www.baxter.com.
January 31, 2006... (From Chemical Business NewsBase - Press Release) Baxter Healthcare Corp (Baxter), the leading global haemophilia therapy provider, has announced that accumulated sales of Advate [Antihaemophilic Factor (Recombinant), Plasma/Albumin-Free...

Benitec delays IND filing for HIV/AIDS therapeutic pending resolution of manufacturing result.
January 31, 2006... (From Chemical Business NewsBase - Press Release) Benitec Ltd, a leading developer of RNA interference (RNAi)-based therapeutics, has announced that the Investigational New Drug (IND) filing with the US Food & Drug Administration (FDA)...

Rockwell Medical Technologies Inc signs agreement with Genpharm Inc for concentrate distribution in Canada.
January 31, 2006... (From Chemical Business NewsBase - Press Release) Rockwell Medical Technologies Inc (Rockwell) has signed an exclusive distribution agreement with Genpharm Inc of Toronto, Canada. The distribution agreement calls for Genpharm to purchase...

Codexis and Bristol-Myers Squibb extend the term of research agreement.
January 31, 2006... (From Chemical Business NewsBase - Press Release) Codexis Inc has extended the term of an existing research agreement with Bristol-Myers Squibb Co. Codexis also announced that it will receive an undisclosed milestone payment for having...

Provectus receives fourth pharmaceutical patent for anti-cancer agents.
January 31, 2006... (From Chemical Business NewsBase - Press Release) Provectus Pharmaceuticals Inc (Provectus) has received the company's fourteenth US patent (US Patent 6,991,776), which is its fourth US patent for its pharmaceutical products. The patent...

GTx and Gen-Probe to study the ability of research-stage diagnostic test to detect high grade PIN.
January 31, 2006... (From Chemical Business NewsBase - Press Release) GTx Inc entered into an exploratory collaboration with Gen-Probe Inc to evaluate the ability of Gen-Probe's research-stage PCA3 assay to detect high grade prostatic intraepithelial...

Vion Pharmaceuticals announces plans to conduct a pivotal Phase II trial of Cloretazine in elderly poor-risk acute myelogenous leukaemia.
January 31, 2006... (From Chemical Business NewsBase - Press Release) Vion Pharmaceuticals Inc (Vion) plans to conduct a pivotal Phase II trial of its anticancer agent Cloretazine, a unique sulfonylhydrazine alkylating agent. This new trial, Vion CLI-043,...

Isis Pharmaceuticals licenses proprietary antibiotic programme to Achaogen.
January 31, 2006... (From Chemical Business NewsBase - Press Release) Isis Pharmaceuticals Inc (Isis) has licensed its proprietary aminoglycosides programme to Achaogen, a biotechnology company pursuing unique strategies to combat drug-resistant pathogens....

AMDL signs Memorandum of Understanding for clinical trials in Taiwan for its Combination Immunogene Therapy to battle cancer.
January 31, 2006... (From Chemical Business NewsBase - Press Release) AMDL Inc, developer and marketer of tests for the early detection of cancer and other serious diseases, signed a Memorandum of Understanding with Vectorite Biomedica Inc that could lead to...

Bradley Pharmaceuticals enters into licensing agreement with MediGene AG for Polyphenon E ointment.
January 31, 2006... (From Chemical Business NewsBase - Press Release) Bradley Pharmaceuticals Inc (Bradley) has announced that the company has entered into a collaboration and licence agreement with MediGene AG to commercialise Polyphenon E ointment in the...

Peoples Energy declares quarterly dividend payable on 13 Apr 2006; quarterly rate maintained at $0.545/share.
January 31, 2006... (From Chemical Business NewsBase - Press Release) The Board of Directors of Peoples Energy declared a regular quarterly dividend of $0.545/share. The first payment at the new level will be made on 13 Apr 2006 to shareholders of record at...

AmeriGas Propane declares partnership distribution payable on 18 Feb 2006.
January 31, 2006... (From Chemical Business NewsBase - Press Release) Directors of AmeriGas Propane Inc have declared the partnership's regular quarterly distribution of $0.56/limited partnership unit, payable on 18 Feb 2006, to unitholders of record as on...

Denbury Resources completes acquisition of producing and tertiary oil properties.
January 31, 2006... (From Chemical Business NewsBase - Press Release) Denbury Resources Inc announced the completion of its previously announced acquisition of three oil fields that are potential carbon dioxide tertiary oil flood candidates: Tinsley Field...

Hollis-Eden Pharmaceuticals responds to Sources Sought notice from Department of Defense for acute radiation syndrome therapy for US forces.
January 31, 2006... (From Chemical Business NewsBase - Press Release) Hollis-Eden Pharmaceuticals Inc (Hollis-Eden) has responded to the Sources Sought Notice (SSN) from the Department of Defense (DOD) titled, "Seeking Sources in the Advanced Development of...

Ziopharm initiates ZIO-101 Phase I/II myeloma study; company meets milestone for treatment of first patient.
January 31, 2006... (From Chemical Business NewsBase - Press Release) Ziopharm Oncology Inc (Ziopharm) announced that ZIO-101, a novel and proprietary form of organic arsenic, has been administered to the first patient in a Phase I/II trial in advanced...

Caraco Pharmaceutical Laboratories Ltd announces tentative FDA approval for Generic Coreg tablets.
January 31, 2006... (From Chemical Business NewsBase - Press Release) Caraco Pharmaceutical Laboratories Ltd (Caraco) announced that the US Food and Drug Administration (FDA) have granted tentative approval for the company's ANDA for the remaining strengths...

Genesis Bioventures announces United States patent for mad cow disease rapid test.
January 31, 2006... (From Chemical Business NewsBase - Press Release) Genesis Bioventures Inc (GBI) announced that the US Patent and Trademark Office have issued a Notice of Allowance for the Rapid Prion-Detection Assay developed by Prion Developmental...

Hexion Specialty Chemicals completes purchase of coatings & adhesives business from The Rhodia Group.
January 31, 2006... (From Chemical Business NewsBase - Press Release) Hexion Specialty Chemicals Inc (Hexion) has completed its purchase of the decorative coatings and adhesives business unit of The Rhodia Group. The business produces emulsion and powder...

Atherotech files patent application for enhanced cholesterol test technology; new technology achieves more robust performance for VAP cholesterol test.
January 31, 2006... (From Chemical Business NewsBase - Press Release) Atherotech Inc has filed a patent application for a technology improvement that further refines the performance of the company's next-generation VAP Cholesterol Test. The patent...

CombinatoRx and Fovea enter into collaboration to develop novel ophthalmic therapeutics built from synergistic drug combinations.
January 31, 2006... (From Chemical Business NewsBase - Press Release) CombinatoRx Inc and Fovea Pharmaceuticals SA (Fovea) announced collaboration for the potential development and commercialisation of combination drugs to treat ophthalmic diseases. The...

UGI declares common dividend payable on 1 Apr 2006.
January 31, 2006... (From Chemical Business NewsBase - Press Release) Directors of UGI Corp have declared the quarterly dividend of $0.16875/share on the company's common stock. The dividend is payable on 1 Apr 2006 to shareholders of record as on 15 Mar...

Cytori Therapeutics receives $11 M milestone payment from Olympus-Cytori JV.
January 31, 2006... (From Chemical Business NewsBase - Press Release) Cytori Therapeutics Inc has received the $11 M milestone payment from the Olympus-Cytori Joint Venture for receiving the CE Mark for the Celution System. The CE Mark grants regulatory...

HistoRx Inc moves to advance the development and commercialisation of new quantitative tissue based diagnostic tests; three industry leaders bring new level of expertise to emerging molecular diagnostics company.
January 31, 2006... (From Chemical Business NewsBase - Press Release) HistoRx Inc announced the expansion of its senior management team in order to advance the development and commercialisation of the company's first series of molecular diagnostic tests...

PerkinElmer expands maternal health technology for early identification of patients at risk for preeclampsia.
January 31, 2006... (From Chemical Business NewsBase - Press Release) PerkinElmer Inc has secured the exclusive global rights to Placental Protein 13 (PP13), a new prospective biomarker for identifying patients at risk for preeclampsia developed by...

Power3 Medical announces business advisory agreement with Glocap Advisors.
January 31, 2006... (From Chemical Business NewsBase - Press Release) Power3 Medical Products Inc (Power3) has retained Glocap Advisors LLC as its exclusive financial advisor in evaluating strategic alternatives for the company. As Power3 moves forward, the...

FDA accepts IND for Elite Pharmaceuticals once-daily oxycodone product; company's second IND acceptance in pain management.
January 31, 2006... (From Chemical Business NewsBase - Press Release) The FDA has accepted Elite Pharmaceuticals Inc's (Elite) Investigational New Drug (IND) application for its once-daily oxycodone product, traded-named OxyQD. OxyQD utilizes Elite's...

AmeriPath Inc and Specialty Laboratories Inc complete merger.
January 31, 2006... (From Chemical Business NewsBase - Press Release) AmeriPath Inc and Specialty Laboratories Inc announced the completion of the merger, which was originally announced by AmeriPath on 30 Sep 2005. Under the terms of the merger agreement,...

Proteome Systems joins fight against global tuberculosis threat; agreement with Geneva-based Foundation For Innovative New Diagnostics supports development of PXL's novel biomarkers.
January 31, 2006... (From Chemical Business NewsBase - Press Release) Proteome Systems Ltd has signed a formal agreement with the Foundation for Innovative New Diagnostics (FIND) for the development of Proteome Systems's novel Tuberculosis biomarkers for...

Cyanotech retains media relations for consumer public relations campaign; focus on BioAstin natural astaxanthin.
January 31, 2006... (From Chemical Business NewsBase - Press Release) Cyanotech Corp has retained Media Relations Inc, based in Burnsville, MN, for a broad-based public relations campaign for the company's leading product for human nutrition and health,...

Suzano posts R$ 2.996 M 4Q 2005 net loss, reversing gain year-on-year.
January 31, 2006... (From Chemical Business NewsBase - Press Release) Brazilian pulp and paper company Suzano Papel e Celulose announced that in 4Q 2005 it took on a R$ 2.996 M net loss (profit of R$ 136.295 M in 4Q 2004). The company said the loss was...

Petrobras negotiating over 50% share in Astra refinery.
January 31, 2006... (From Chemical Business NewsBase - Press Release) Brazilian state run oil company Petroleo Brasileiro (Petrobras) is still negotiating a share of over 50% in the Astra oil refinery in Texas, for which it signed a memorandum of intent in...

OrthoLogic reports 4Q and 2005 results. [2 tables].
January 31, 2006... (From Chemical Business NewsBase - Company Reports - CBNB) OrthoLogic Corp announced financial results for 4Q and year ended Dec 2005. OrthoLogic reported a net loss of $7.5 M for 4Q 2005 (net loss of $5 M in 4Q 2004). For 2005, the...

Phelps Dodge reports 4Q 2005 net income of $121.3 M, or $1.19/share (includes net special charges of $204.2 M, or $2.01 per share); cash from operating activities of $470.6 M (net of $200 M contributions to trusts). [17 tables].
January 31, 2006... (From Chemical Business NewsBase - Company Reports - CBNB) Phelps Dodge Corp reported consolidated net income of $121.3 M, or $1.19/share, for 4Q ended Dec 2005 and $1556.4 M, or $15.37/share, for year ended Dec 2005 (net income of...

Thoratec reports record 4Q 2005 revenues; 2005 revenues increase 17% to $202 M. [3 tables].
January 31, 2006... (From Chemical Business NewsBase - Company Reports - CBNB) Thoratec Corp reported financial results for 4Q and year ended Dec 2005. For 4Q 2005, Thoratec reported revenues of $54.8 M (+13% over $48.3 M in 4Q 2004). For 4Q 2005, Thoratec...

Cytokinetics Inc reports 4Q and year end 2005 financial results. [2 tables].
January 31, 2006... (From Chemical Business NewsBase - Company Reports - CBNB) Cytokinetics Inc reported revenues from research and development collaborations of $2.1 M for 4Q ended Dec 2005 ($2.2 M in 4Q ended Dec 2004). Net loss for 4Q 2005 was $11.1 M...

Haemonetics reports 3Q 2005-2006 earnings. [5 tables].
January 31, 2006... (From Chemical Business NewsBase - Company Reports - CBNB) Haemonetics Corp reported net revenue of $106 M for 3Q ended Dec 2005 and $309 M for nine months ended Dec 2005. Diluted net earnings/share for 3Q 2005-2006 were $1.02 and $1.89...

Wyeth reports earnings results for 4Q and year 2005. [3 tables].
January 31, 2006... (From Chemical Business NewsBase - Company Reports - CBNB) Wyeth reported results for 4Q and full year ended Dec 2005. Worldwide net revenue increased to $4.7 bn for 4Q 2005 and to $18.8 bn for year ended Dec 2005. Enbrel sales in North...

Steris Corp announces 3Q 2005-2006 results. [5 tables].
January 31, 2006... (From Chemical Business NewsBase - Company Reports - CBNB) Steris Corp announced financial results for 3Q ended Dec 2005. Revenues for 3Q 2005-2006 increased to $287.5 M ($273.8 M in 3Q ended De3c 2004). Net income for 3Q 2005-2006 was...

Elan reports 4Q and full-year 2005 financial results. [12 tables].
January 31, 2006... (From Chemical Business NewsBase - Company Reports - CBNB) Elan Corp plc announced its 4Q and year ended Dec 2005 financial results. The net loss for 4Q 2005 amounted to $58.3 M (-46% over $107.1 M in 4Q 2004). For 2005, the net loss...

Sepracor announces 4Q and 2005 results; Sepracor reports first profitable year; 2005 product revenues increase by 116% over 2004. [2 tables].
January 31, 2006... (From Chemical Business NewsBase - Company Reports - CBNB) Sepracor Inc announced its consolidated financial results for 4Q and year ended Dec 2005. For 4Q 2005, Sepracor's consolidated revenues were about 311.1 M, of which revenues from...

Leiner Health Products reports 3Q 2005-2006 results; gross margins improve to 23%. [3 tables].
January 31, 2006... (From Chemical Business NewsBase - Company Reports - CBNB) Leiner Health Products Inc announced its financial results for 3Q and nine months ended Dec 2005. Net sales for 3Q 2005-2006 were $181.2 M (-4.3% from $189.3 M in 3Q 2004-2005)....

Connetics reports 4Q 2005 revenues of $41.3 M and EPS of $0.4. [2 tables].
January 31, 2006... (From Chemical Business NewsBase - Company Reports - CBNB) Connetics Corp reported results for 4Q and year ended Dec 2005. Net income for 4Q 2005 of $15.1 M, or $0.4 earnings/share (EPS) on a diluted "If-Converted" basis (net income of $6...

Techne Corp releases unaudited results for 2Q 2005-2006. [5 tables].
January 31, 2006... (From Chemical Business NewsBase - Company Reports - CBNB) Techne Corp's consolidated net earnings increased to $16.5 M for 2Q ended Dec 2005 (net earnings of $14.9 M for 2Q ended Dec 2004). For 1H ended Dec 2005, Techne's consolidated...

TriPath Imaging announces 4Q and year 2005 results. [2 tables].
January 31, 2006... (From Chemical Business NewsBase - Company Reports - CBNB) TriPath Imaging Inc reported that worldwide revenues for year ended Dec 2005 increased to $86 M ($68.5 M in year ended Dec 2004). Worldwide sales of reagents and disposables were...

GE facility provides customized silicones and customized service for faster development of medical applications.
January 31, 2006... (From Chemical Business NewsBase - Press Release) GE-Silicones' full-service facility in Garrett, IN, US, was recently expanded to help customers achieve a competitive advantage though rapid development of products featuring versatile GE...

Tough Lexan polycarbonate sheet from GE gives clear advantage to awe-inspiring Shanghai South Railway Station Design.
January 31, 2006... (From Chemical Business NewsBase - Press Release) The newest, largest round roof of its kind in the world - that of the massive new Shanghai South Railway Station - is being constructed of clear, tough Lexan polycarbonate sheet from GE....

Dainippon Ink & Chemical 9 months 2005: Electronics and information materials.
January 31, 2006... (From Chemical Business NewsBase - Company Reports - CBNB) For the first nine months of its fiscal 2005 (1 Apr to 31 Dec 2005), the Electronics & Information Materials segment of Dainippon Ink & Chemicals Inc has reported sales of Yen...

Dainippon Ink & Chemical 9 months 2005: High performance and applied products.
January 31, 2006... (From Chemical Business NewsBase - Company Reports - CBNB) For the first nine months of its fiscal 2005 (1 Apr to 31 Dec 2005), the High Performance and Applied Products segment of Dainippon Ink & Chemicals Inc has reported sales of Yen...

Dainippon Ink & Chemical 9 months 2005: Industrial materials.
January 31, 2006... (From Chemical Business NewsBase - Company Reports - CBNB) For the first nine months of its fiscal 2005 (1 Apr to 31 Dec 2005), the Industrial Materials segment of Dainippon Ink & Chemicals Inc has reported sales of: Japan Yen 116.8 bn...

Dainippon Ink & Chemical 9 months 2005: Graphic arts materials.
January 31, 2006... (From Chemical Business NewsBase - Company Reports - CBNB) For the first nine months of its fiscal 2005 (1 Apr to 31 Dec 2005), the Graphic Arts Materials segment of Dainippon Ink & Chemicals Inc has reported sales of: Japan Yen 77.4 bn...

Dainippon Ink & Chemical 9 months 2005: Segment results. [1 table].
January 31, 2006... (From Chemical Business NewsBase - Company Reports - CBNB) For the first nine months of its fiscal 2005 (1 Apr to 31 Dec 2005), Dainippon Ink & Chemicals Inc has reported turnover of Yen 757,072 M (Yen 747,184 M for the same period of its...

Dainippon Ink & Chemical 9 months 2005: Consolidated operating results.
January 31, 2006... (From Chemical Business NewsBase - Company Reports - CBNB) For the first nine months of its fiscal 2005 (1 Apr to 31 Dec 2005), Dainippon Ink & Chemicals Inc has reported turnover of Yen 757,072 M (Yen 747,184 M for the same period of its...

Ciba Specialty Chemicals 2005: Overview - full year 2005 - increased sales, with Asia Pacific driving growth.
January 31, 2006... (From Chemical Business NewsBase - Company Reports - CBNB) For its fiscal 2005, Ciba Specialty Chemicals has reported sales of SFR 7.4 bn (+6% Swiss francs and 4% in local currencies on its fiscal 2004), reflecting sales price increases,...

Ciba Specialty Chemicals 2005: Overview - 4Q 2005 - financial highlights.
January 31, 2006... (From Chemical Business NewsBase - Company Reports - CBNB) For its 4Q 2005, Ciba Specialty Chemicals has reported sales SFR 1.9 bn (+7% in Swiss francs and +1% in local currencies). Sales in Asia Pacific continued to rise, while in Europe...

Ciba Specialty Chemicals 2005: Investing in Asia.
January 31, 2006... (From Chemical Business NewsBase - Company Reports - CBNB) A key part of Ciba Speciality Chemicals' strategy is to continue to strengthen its presence in Asia, which remains a core growth region. Earlier in 2005, a new R&D centre was...

Ciba Specialty Chemicals 2005: Segment overview - Coating effects was mixed, with strong growth in some industries.
January 31, 2006... (From Chemical Business NewsBase - Company Reports - CBNB) For its fiscal 2005, Ciba Speciality Chemicals has reported on its Coating Effects segment. Performance In Coating Effects was mixed, with strong growth In some Industries -...

Ciba Specialty Chemicals 2005: Segment overview - Water & Paper Treatment, strong sales price increases.
January 31, 2006... (From Chemical Business NewsBase - Company Reports - CBNB) For its fiscal 2005, Ciba Speciality Chemicals has reported on its Water & Paper Treatment segment. Sales for its fiscal increased 19%, driven mainly by the Raisio Chemicals...

Ciba Specialty Chemicals 2005: Segment overview - Textile Effects, profitability recovered in 2H 2005.
January 31, 2006... (From Chemical Business NewsBase - Company Reports - CBNB) For its fiscal 2005, Ciba Speciality Chemicals has reported on its textile Effects segment. 2005 sales were on a similar level to 2004 at SFR 1.3 bn, with very strong growth in...

Ciba Specialty Chemicals 2005: Segment overview - Plastic Additives strong, with good sales price increases.
January 31, 2006... (From Chemical Business NewsBase - Company Reports - CBNB) For its fiscal 2005, Ciba Speciality Chemicals has reported on its Plastic Additives segment. Sales for the full year 2005 remain high at SFR 1.9 bn (+2% in Swiss francs and 1% in...

Imerys 2005: Speciality minerals.
January 31, 2006... (From Chemical Business NewsBase - Company Reports - CBNB) For its fiscal 2005, Imerys Group has reported on its Speciality Minerals business. In 2005, the business group's markets were difficult overall: Performance minerals markets...

Imerys 2005: Pigments for paper.
January 31, 2006... (From Chemical Business NewsBase - Company Reports - CBNB) For its fiscal 2005, Imerys Group has reported on its Pigments for Paper business. After a good 2004 (+ 5.1%), the world market for printing and writing paper, the business...

Imerys 2005: Consolidated sales - 4Q 2005.
January 31, 2006... (From Chemical Business NewsBase - Company Reports - CBNB) For its 4Q 2005, Imerys Group has reported total sales of EUR 801.3 M (EUR 707.5 M for its 4Q 2004), of which: speciality minerals EUR 216 M (EUR 192.5 M), pigments for paper EUR...

Imerys 2005: Consolidated sales - FY2005.
January 31, 2006... (From Chemical Business NewsBase - Company Reports - CBNB) For its fiscal 2005, Imerys Group has reported total sales of EUR 3045.2 M (EUR 2870.5 M for its fiscal 2004), of which: speciality minerals EUR 814.9 M (EUR 795.1 M), pigments...

Sekisui Chemical 9 months 2005: High performance plastics.
January 31, 2006... (From Chemical Business NewsBase - Company Reports - CBNB) For the first nine months of its fiscal 2005 (1 Apr to 31 Dec 2005), Sekisui Chemical Co Ltd has reported on its high performance plastics segment. Sales of IT materials were...

Sekisui Chemical 9 months 2005: Business segment information. [2 tables].
January 31, 2006... (From Chemical Business NewsBase - Company Reports - CBNB) For the first nine months of its fiscal 2005 (1 Apr to 31 Dec 2005), Sekisui Chemical Co Ltd has reported turnover of Yen 649,428 M (Yen 633,209 M for the same period of its...

Imerys 2005: Refractories, abrasives & filtration.
January 31, 2006... (From Chemical Business NewsBase - Company Reports - CBNB) For its fiscal 2005, Imerys Group has reported on its Refractories, Abrasives & Filtration business. The business group's markets showed contrasting trends in 2005: After a good...

Imerys 2005: Materials & monolithics.
January 31, 2006... (From Chemical Business NewsBase - Company Reports - CBNB) For its fiscal 2005, Imerys Group has reported on its Materials & Monolithics business. The business group benefited from overall firm markets: The French building materials...

Sekisui Chemical 9 months 2005: Geographical segment information. [2 tables].
January 31, 2006... (From Chemical Business NewsBase - Company Reports - CBNB) For the first nine months of its fiscal 2005 (1 Apr to 31 Dec 2005), Sekisui Chemical Co Ltd has reported turnover of Yen 649,428 M (Yen 633,209 M for the same period of its...

Starpharma quarter to 31 Dec 2005: Cash flow report.
January 31, 2006... (From Chemical Business NewsBase - Company Reports - CBNB) For the fiscal quarter ending 31 Dec 2005, Australian company Starpharma Holdings Ltd has reported turnover of A$ 543,000, R&D spending of A$1.824 M, and an operating loss of...

TransCanada Reports 2005 net Income of $1.2 bn.
January 31, 2006... (From Chemical Business NewsBase - Company Reports - CBNB) For its 4Q 2005, TransCanada Corp has reported net income of $235 M (+27% on its 4Q 2004) and EPS of $0.48. For its fiscal 2005, the company reported net income of $852 M (+8% on...

Sekisui Chemical 9 months 2005: Financial and operating results.
January 31, 2006... (From Chemical Business NewsBase - Company Reports - CBNB) For the first nine months of its fiscal 2005 (1 Apr to 31 Dec 2005), Sekisui Chemical Co Ltd has reported turnover of Yen 649,428 M (Yen 633,209 M for the same period of its...

UPM 2005: Magazine papers.
January 31, 2006... (From Chemical Business NewsBase - Company Reports - CBNB) For its 4Q 2005 (ends 31 Dec 2005), the Magazine Papers segment of UPM-Kymmene Corp has reported sales of EUR 935 M (EUR 876 M for its 4Q 2004), EBITDA of EUR 171 M (EUR 113 M),...

UPM 2005: Newsprint.
January 31, 2006... (From Chemical Business NewsBase - Company Reports - CBNB) For its 4Q 2005 (ends 31 Dec 2005), the Newsprint segment of UPM-Kymmene Corp has reported sales of EUR 381 M (EUR 342 M for its 4Q 2004), EBITDA of EUR 77 M (EUR 53 M), operating...